 | • レポートコード：MRC2109A047 • 出版社/出版日：Transparency Market Research / 2021年6月7日 • レポート形態：英文、PDF、172ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、ガリウム-68の世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、主要インサイト、エンドユーザー別（病院、診断センター、その他）分析、用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しております。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・ガリウム-68の世界市場規模：エンドユーザー別（病院、診断センター、その他） ・ガリウム-68の世界市場規模：用途別 ・ガリウム-68の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Gallium-68 Market – Scope of Report
TMR’s report on the global gallium-68 market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global gallium-68 market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global gallium-68 market during the forecast period.
The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global gallium-68 market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global gallium-68 market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global gallium-68 market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global gallium-68 market.
The report delves into the competitive landscape of the global gallium-68 market. Key players operating in the global gallium-68 market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global gallium-68 market that have been profiled in this report.
Key Questions Answered in Gallium-68 Market Report
What is the revenue forecast for the global gallium-68 market in terms of revenue for the period 2021–2031?
How would various dynamics such as drivers, restraints, opportunities, and trends impact the market?
What is the market size and estimation for the gallium-68 market across regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
Which regional market is poised to expand at a significant CAGR during the forecast period?
Which product segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?
Research Methodology
A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global gallium-68 market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary research sources referred to by analysts during the production of the global gallium-68 market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the gallium-68 market as primary methods.
These primary research respondents have provided exclusive information during interviews, which serves as a validation from the gallium-68 market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global gallium-68 market with accuracy. The study also uses the top-down approach to assess the revenue of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global gallium-68 more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Gallium-68 Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Gallium-68 Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Health Care Industry Overview
5.2. Radioactive Material Transport Guidelines
5.3. Radiation Protection Guidelines
5.4. Installed PET Scanner Base Data, by Region
5.5. Number of PET/CT Scan, by Regions (2019)
5.6. FDA Approved Radiopharmaceuticals Products
5.7. PET Drug Workflow
5.8. Number of Radiotherapy Center: by Major Countries
5.9. Clinical Trials for Gallium-68 Radioisotope
5.10. COVID-19 Impact Analysis
6. Global Gallium-68 Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Gallium-68 Market Value Forecast, by Application, 2017–2031
6.3.1. Hospitals
6.3.2. Diagnostic Centers
6.3.3. Others
6.4. Global Gallium-68 Market Attractiveness, by Application
7. Global Gallium-68 Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Gallium-68 Market Value Forecast, by Application, 2017–2031
7.3.1. Oncology
7.3.2. Cardiology
7.3.3. Neurology
7.3.4. Others
7.4. Global Gallium-68 Market Attractiveness, by Application
8. Global Gallium-68 Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Gallium-68 Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Gallium-68 Market Attractiveness, by Country/Region
9. North America Gallium-68 Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Gallium-68 Market Value Forecast, by Application, 2017–2031
9.2.1. Hospitals
9.2.2. Diagnostic Centers
9.2.3. Others
9.3. North America Gallium-68 Market Value Forecast, by Application, 2017–2031
9.3.1. Oncology
9.3.2. Cardiology
9.3.3. Neurology
9.3.4. Others
9.4. North America Gallium-68 Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Gallium-68 Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By Application
9.5.3. By Country
10. Europe Gallium-68 Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Gallium-68 Market Value Forecast, by Application, 2017–2031
10.2.1. Hospitals
10.2.2. Diagnostic Centers
10.2.3. Others
10.3. Europe Gallium-68 Market Value Forecast, by Application, 2017–2031
10.3.1. Oncology
10.3.2. Cardiology
10.3.3. Neurology
10.3.4. Others
10.4. Europe Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Gallium-68 Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Gallium-68 Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Gallium-68 Market Value Forecast, by Application, 2017–2031
11.2.1. Hospitals
11.2.2. Diagnostic Centers
11.2.3. Others
11.3. Asia Pacific Gallium-68 Market Value Forecast, by Application, 2017–2031
11.3.1. Oncology
11.3.2. Cardiology
11.3.3. Neurology
11.3.4. Others
11.4. Asia Pacific Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Gallium-68 Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Gallium-68 Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Gallium-68 Market Value Forecast, by Application, 2017–2031
12.2.1. Hospitals
12.2.2. Diagnostic Centers
12.2.3. Others
12.3. Latin America Gallium-68 Market Value Forecast, by Application, 2017–2031
12.3.1. Oncology
12.3.2. Cardiology
12.3.3. Neurology
12.3.4. Others
12.4. Latin America Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Gallium-68 Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Gallium-68 Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Gallium-68 Market Value Forecast, by Application, 2017–2031
13.2.1. Hospitals
13.2.2. Diagnostic Centers
13.2.3. Others
13.3. Middle East & Africa Gallium-68 Market Value Forecast, by Application, 2017–2031
13.3.1. Oncology
13.3.2. Cardiology
13.3.3. Neurology
13.3.4. Others
13.4. Middle East & Africa Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Gallium-68 Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Company Profiles
14.1.1. Siemens Healthineers AG
14.1.1.1. Company Overview
14.1.1.2. Company Financials
14.1.1.3. Growth Strategies
14.1.1.4. SWOT Analysis
14.1.2. ITM Isotopen Technologien München AG
14.1.2.1. Company Overview
14.1.2.2. Company Financials
14.1.2.3. Growth Strategies
14.1.2.4. SWOT Analysis
14.1.3. Advanced Accelerator Applications (a Novartis AG Company)
14.1.3.1. Company Overview
14.1.3.2. Company Financials
14.1.3.3. Growth Strategies
14.1.3.4. SWOT Analysis
14.1.4. Telix Pharmaceuticals
14.1.4.1. Company Overview
14.1.4.2. Company Financials
14.1.4.3. Growth Strategies
14.1.4.4. SWOT Analysis
Table 1: Health Care Industry Overview
Table 2: North America Installed Base
Table 3: Europe Installed Base
Table 4: Europe Installed Base
Table 5: Asia –Pacific Installed Base
Table 6: ROW Installed Base
Table 7: Number of PET/CT Scan by Continent
Table 8: Number of PET/CT Scan Performed in Asia
Table 9: Number of PET/CT Scan Performed in Eastern Europe and Northern Asia
Table 10: Number of PET/CT Scan Performed in Latin America & Caribbean
Table 11: Number of PET/CT Scan Performed in Middle East
Table 12: Number of PET/CT Scan Performed in Africa
Table 13: Number of PET/CT Scan Performed in High-income Countries (2018)
Table 14: FDA Approved Radiopharmaceuticals Products
Table 15: FDA Approved Radiopharmaceuticals Products
Table 16: FDA Approved Radiopharmaceuticals Products
Table 17: Number of Radiotherapy Centers, by Country
Table 18: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 19: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 20: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 21: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 22: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 23: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 24: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 25: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 26: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 27: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 28: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 29: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 30: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 31: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 32: Clinical trials involving the use of 68Ga radiopharmaceutical
Table 33: Global Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 34: Global Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 35: Global Gallium-68 Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 36: North America Gallium-68 Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 37: North America Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 38: North America Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 39: Europe Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 40: Europe Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Europe Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 42: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 43: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 44: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 45: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 46: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 47: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 48: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 49: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 50: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031